We are live on ! Find out more
O

OppenheimerFunds Portfolio holdings

AUM $80.4B
1-Year Est. Return 15.1%
This Fund
S&P 500
This Quarter Est. Return
+0.47%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
AUM
$80.2B
AUM Growth
-$2.64B
Cap. Flow
-$1.24B
Cap. Flow %
-1.54%
Top 10 Hldgs %
15.46%
Holding
1,891
New
54
Increased
680
Reduced
1,031
Closed
114

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$955M
2
C icon
Citigroup
C
+$523M
3
NKTR icon
Nektar Therapeutics
NKTR
+$334M
4
SLB icon
SLB Ltd
SLB
+$292M
5
BABA icon
Alibaba
BABA
+$275M

Sector Composition

Rank Sector Weight
1 Financials 15.67%
2 Consumer Discretionary 14.85%
3 Healthcare 13.25%
4 Technology 13.05%
5 Energy 11.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAL icon
901
Caleres
CAL
$447M
$1.76M ﹤0.01%
52,514
-2,626
-5% -$80.5K
KSS icon
902
Kohl's
KSS
$2.16B
$1.76M ﹤0.01%
26,918
-555,871
-95% -$35.3M
VYX icon
903
NCR Voyix
VYX
$1.19B
$1.75M ﹤0.01%
90,635
-2,102
-2% -$44.3K
KG
904
Kestrel Group
KG
$68M
$1.75M ﹤0.01%
13,448
-8
-0.1% -$1.11K
NVR icon
905
NVR
NVR
$17.3B
$1.74M ﹤0.01%
620
-3,085
-83% -$9.81M
LPNT
906
DELISTED
LifePoint Health, Inc.
LPNT
$1.74M ﹤0.01%
36,914
-185
-0.5% -$8.9K
THS
907
DELISTED
Treehouse Foods
THS
$1.73M ﹤0.01%
45,262
+6,257
+16% +$272K
INGR icon
908
Ingredion
INGR
$6.48B
$1.73M ﹤0.01%
13,416
+1,408
+12% +$188K
TOL icon
909
Toll Brothers
TOL
$14.5B
$1.71M ﹤0.01%
39,537
+5,357
+16% +$252K
WPX
910
DELISTED
WPX Energy, Inc.
WPX
$1.7M ﹤0.01%
115,356
+41,585
+56% +$599K
KMB icon
911
Kimberly-Clark
KMB
$37.5B
$1.69M ﹤0.01%
15,348
-9,778
-39% -$1.11M
HA
912
DELISTED
Hawaiian Holdings, Inc.
HA
$1.69M ﹤0.01%
43,626
-406
-0.9% -$15.2K
GIII icon
913
G-III Apparel Group
GIII
$1.55B
$1.68M ﹤0.01%
44,595
-5,055
-10% -$188K
TTEK icon
914
Tetra Tech
TTEK
$8.7B
$1.67M ﹤0.01%
170,750
-26,890
-14% -$266K
AIT icon
915
Applied Industrial Technologies
AIT
$12.9B
$1.65M ﹤0.01%
22,606
-5,929
-21% -$425K
L icon
916
Loews
L
$24.6B
$1.64M ﹤0.01%
33,002
-14,002
-30% -$708K
OHI icon
917
Omega Healthcare
OHI
$15.4B
$1.64M ﹤0.01%
60,661
+4,001
+7% +$107K
FINL
918
DELISTED
Finish Line
FINL
$1.62M ﹤0.01%
119,707
+19,142
+19% +$221K
NUE icon
919
Nucor
NUE
$60.5B
$1.6M ﹤0.01%
26,240
-20,848
-44% -$1.38M
UPBD icon
920
Upbound Group
UPBD
$1.26B
$1.58M ﹤0.01%
183,642
+19,615
+12% +$188K
BKR icon
921
Baker Hughes
BKR
$58B
$1.58M ﹤0.01%
57,064
-19,366
-25% -$592K
POST icon
922
Post Holdings
POST
$4.27B
$1.58M ﹤0.01%
31,949
+2,659
+9% +$134K
WPG
923
DELISTED
Washington Prime Group Inc.
WPG
$1.58M ﹤0.01%
26,262
+3,930
+18% +$230K
MAC icon
924
Macerich
MAC
$7.52B
$1.57M ﹤0.01%
27,980
+2,828
+11% +$172K
MPT
925
Medical Properties Trust
MPT
$2.89B
$1.56M ﹤0.01%
120,173
+13,116
+12% +$168K

Similar funds

OppenheimerFunds's Q1 2018 Portfolio in Review

As of Q1 2018, OppenheimerFunds held 1,891 positions worth $80.2B, down 3.2% from $82.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

OppenheimerFunds's Q1 2018 filing shows 54 new, 680 increased, 1,031 reduced and 114 closed positions. Its largest new stake was Avaya Holdings Corp. Common Stock: 5,049,928 shares worth $113M. The largest sale was Alphabet (Google) Class C, an estimated $955M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • OppenheimerFunds's largest Q1 2018 buy was Avaya Holdings Corp. Common Stock: 5,049,928 shares worth $113M.
  • OppenheimerFunds added most to Alphabet (Google) Class A in Q1 2018, an estimated $639M increase.
  • OppenheimerFunds's biggest Q1 2018 reduction was Alphabet (Google) Class C, cutting an estimated $955M.
  • OppenheimerFunds fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $77.3M.
  • OppenheimerFunds's ten largest holdings make up 15% of its $80.2B portfolio in Q1 2018.
  • OppenheimerFunds opened 54 new positions and closed 114 in Q1 2018.
  • OppenheimerFunds's portfolio value fell 3.2% quarter-over-quarter to $80.2B.

Based on OppenheimerFunds's 13F filing for Q1 2018, filed 11 May 2018.